Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))
- (2025): Ingen-Housz-Oro S+, Therapie Mar, Online ahead of print [REVIEW]
- (2023): Spina Tensini T+, HLA Mar, Online ahead of print (pharmacogenomics)
- (2022): Fong SL+, J Clin Pharmacol Mar, Online ahead of print
- (2022): Martins JC+, An Bras Dermatol Apr, Online ahead of print
- (2021): Alfares I+, CNS Drugs Feb, Online ahead of print [REVIEW]
DRESS syndrome (Drug-induced hypersensitivity syndrome)
- (2025): Qian J+, Seizure 125, 37-43 (pharmacovigilance / pharmacoepidemiology)
- (2012): Descamps V, Rev Prat (French) 62(10), 1347
- (2015): Farshchian M+, Clin Cosmet Investig Dermatol 8, 5326%
- (1999): Coral P+, Arq Neuropsiquiatr (Portuguese) 57(3B), 860-2 (1 case / male)
- (1976): Critchley EM+, J Neurol Neurosurg Psychiatry 39(5), 498-503 (association)
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN)
- (2021): Sivagourounadin K+, Curr Drug Saf Jun, Online ahead of print [REVIEW]
- (2011): Barvaliya M+, J Postgrad Med 57(2), 11519%
Toxic epidermal necrolysis (Lyell's syndrome)
- (2021): Sivagourounadin K+, Curr Drug Saf Jun, Online ahead of print [REVIEW]
- (2011): Barvaliya M+, J Postgrad Med 57(2), 11582%